Nasal spray offers new hope for stubborn depression

NCT ID NCT05660642

Recruiting now Symptom relief Sponsor: Beckley Psytech Limited Source: ClinicalTrials.gov ↗

First seen Dec 16, 2025 · Last updated May 16, 2026 · Updated 14 times

Summary

This study tests an experimental nasal spray called BPL-003, given with psychological support, in 64 adults whose depression has not improved with at least two prior treatments. The main goal is to see if the spray is safe and tolerable, and to measure its effects on mood. Participants will receive one or two doses and be monitored for side effects and changes in depression symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hammersmith Medicines Research
RECRUITING

London, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
King's College London, Clinical Trials Facility
COMPLETED

London, United Kingdom
MAC Clinical Research
RECRUITING

Liverpool, L34 1BH, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

TREATMENT-RESISTANT DEPRESSION